Venous-only transcatheter closure: a safe and effective strategy for patent ductus arteriosus | [Pakistan Heart Journal • 2024]

Author(s):

1. Asma Kanwal: Rawalpindi institute of Cardiology, Rawalpindi, Punjab, Pakistan

2. Abdul Malik Sheikh: Rawalpindi institute of Cardiology, Rawalpindi, Punjab, Pakistan

3. Tauqeer Akbar: Rawalpindi institute of Cardiology, Rawalpindi, Punjab, Pakistan

4. Tayyaba Sehar: Rawalpindi institute of Cardiology, Rawalpindi, Punjab, Pakistan

5. Kiran Azim Sheikh: Rawalpindi institute of Cardiology, Rawalpindi, Punjab, Pakistan

6. Sidra Talat: Rawalpindi institute of Cardiology, Rawalpindi, Punjab, Pakistan

Abstract:

Objectives: This study aimed to assess the feasibility and effectiveness of transcatheter device closure of patent ductus arteriosus (PDA) exclusively through an isolated venous route . Methodology: A retrospective descriptive study was conducted at the Rawalpindi Institute of Cardiology. Patient data from 2019 to 2023 undergoing PDA closure us ing transcatheter devices were analyzed. PDA diagnosis was established via echocardiography, and the procedure was performed solely through a venous line under fluoroscopy, omitting the traditional method of using both arterial and venous lines. Results: A total of 212 patients underwent transcatheter PDA closure through a venous -only route, with ages ranging from 6 months to 14 years. The mean weight was 10.07 kg (range: 5 kg to 27 kg, SD 4.43). The average procedure time was 30 ± 10.3 minutes (range: 15. 0 to 65 minutes), and fluoroscopy time was 5.4 ± 3.18 minutes (range: 2.1 to 19 minutes). Immediate closure was achieved in all patients, with no residual leaks or device embolization observed. Additionally, there were no reported complications such as arr hythmia, vascular access issues, or significant blood loss. No cases of aortic or pulmonary stenosis were identified, and no deaths occurred. All patients were discharged within 48 hours post -procedure. Conclusion: Transcatheter closure of PDA exclusively through the venous route, without the use of an arterial line, demonstrates itself as an effective and safe method for PDA closure .

Page(s): 29-32

DOI: 10.47144/phj.v57i1.2652

Published: Journal: Pakistan Heart Journal, Volume: 57, Issue: 1, Year: 2024

Keywords:

Congenital heart disease , Patent ductus arteriosus , Transcatheter closure , venous route

References:

[1] Choi DY,Kim NY,Jung MJ,Kim SH . .The results of transcatheter occlusion of patent ductus arteriosus: success rate and complications over 12 years in a single centre. Korean Circ J., : .

[2] Ye Z,Li Z,Yi H,Zhu Y,Sun Y,Li P .2020 .Percutaneous device closure of pediatirc patent ductus arteriosus through femoral artery guidance by transthoracic echocardiography without radiation and contrast agents. J Cardiothorac Surg, 15 : 1-6.

[3] Liu J,Gao L,Tan HL,Zheng QH,Liu L,Wang Z .2018 .Transcatheter closure through single venous approach for young children with patent ductus arteriosus: A retrospective study of 686 cases. , 97(35) : e11958.

[4] Ammar W,Basset HA,Al Faramawy A,Hegazy T,Sharaf Y. .2020 .Comparison of isolated venous approach with the standard approach in children undergoing patent ductus arteriosus device closure. Egypt Heart J, 72 : 67.

[5] Sheikh AM,Duke AK,Sattar H .2018 .Transcatheter closure of Patent Ductus Arteriosus through only venous route. J Pak Med Assoc, 68(3) : 469-70.

[6] Gruenstein DH,Ebeid M,Radtke W,Moore P,Holzer R,Justino H .2017 .Transcatheter closure of patent ductus arteriosus using the AMPLATZER duct occluder II (ADO II). Catheter Cardiovasc Interv, 89 : 1118-28.

[7] Putra ST,Djer MM,Idris NS,Sastroasmoro S. .2016 .Transcatheter closure of patent ductus arteriosus in adolescents and adults: a case series. Acta Med Indones, 48 : 314-9.

[8] Morville P,Akhavi A .2017 .Transcatheter closure of hemodynamically significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS. Catheter Cardiovasc Interv, 90 : 612-7.

[9] Garg G,Shirivastawa A,Tyagi H,Reddy SP .2013 .Transcatheter device closure of patent ductus arteriosus without arterial access - Single institution experience. , 65(5) : 546-51.

[10] Thanopoulos BV,Ninios V,Dardas P,Giannopoulos A,Deleanou D,Iancovici S. .2016 .Catheter closure through a venous approach of patent ductus arteriosus in small pediatric patients using combined angiographic and echocardiographic guidance. Am J Cardiol, 118(10) : 1558-62.

[11] Andraska EA,Jackson T,Chen H,Gallagher KA,Eliason JL,Coleman DM .2017 .Natural history of iatrogenic pediatric femoral artery injury. Ann Vasc Surg, 42 : 205-13.

[12] Abdelghani E,Cua CL,Giver J,Rodriguez V .2021 .Thrombosis prevention and anticoagulation management in the pediatric patient with congenital heart disease. Cardiol Ther, 10(2) : 325-48.

[13] Naganur SH,Pruthvi CR,Bootla D,Prasad K,Krishna Santosh V,Barwad P .2020 .Transcatheter closure of patent ductus arteriosus in a child with IVC interruption through standard femoral access: a case report. Egypt Heart J, 72 : 34.

[14] Al-Akhfash AA,Almesned AA .2017 .PDA device closure with and without arterial access. Interv Cardiol J, 3(2) : 61.

[15] Baykan A,Narin N,Özyurt A,Argun M,Pamukçu Ö,Onan SH .2015 .Do we need a femoral artery route for transvenous PDA closure in children with ADO-I? Anatol J Cardiol. , 15(3) : 242-7.

[16] Jung JW .2010 .Recent strategies and outcomes of transcatheter closure for patent ductus arteriosus. Korean Circ J, 40(5) : 216.

Citations

Downloads

Views